A Study to Assess Growth in Children With Idiopathic Short Stature Read more about A Study to Assess Growth in Children With Idiopathic Short Stature
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma Read more about Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs (IGNYTE-3) Read more about VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs (IGNYTE-3)
Long-Term Outcomes of Children With Congenital CMV in New York State Read more about Long-Term Outcomes of Children With Congenital CMV in New York State
A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases Read more about A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors Read more about A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia Read more about A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders Read more about ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1 Read more about A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1